BBIO Enters $500M At-The-Market Offering with Goldman Sachs, Leerink Partners, Terminates Prior Agreement
BridgeBio Pharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $65.36
-4.0% in 1d after detection
Post-detection moves
1h
—
1d
-4.0%
3d
+1.8%
7d
-2.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS